GI Windows Secures $14.6M for Product Development

GI Windows Secures $14.6M for Product Development

A medical device company has raised $14.6 million for supporting product development and clinical studies for the company's patented technology.        

FREMONT, CA: A privately-held medical device company, GI Windows, has bagged $14.6 million through Series A financing, led by Asia-focused healthcare investment firm GT Healthcare Capital Partners and Silicon Valley-based Sonder Capital. This funding will be further used to support product development and clinical studies for the company's patented technology in the next generation of clinical procedures and tissue fusion. The company is centered on creating the first fundamental breakthrough in anastomoses technology for a very long time. This investment represents areas of significant clinical unmet need with large and growing market opportunities.     

GI Windows has made significant strides over the past 12 months in R&D and clinical procedural development. The company's technology is poised to demonstrate improved clinical outcomes and reduce healthcare costs for patients and providers. Along with the Series A investment, the board has also elected Payson Coleman as an independent board member. Payson Coleman will be joining the recent board of Fred Moll, MD, Jay Watkins, Christopher Thompson, MD, Peter Rogal and Colby Wood.    

GI Windows is a clinical-stage, venture-backed medical device organization dedicated to developing the first fundamental breakthrough in Endoscopic & Surgical Anastomotic technology in both delivery and tissue fusion. The company is working on this new development to change the paradigm of surgical anastomoses and bypass. The company is creating a new category in healthcare to create less invasive surgery & mitigate healthcare costs for patients. 

Check out: Top Healthcare Tech Consulting Companies